Author:
Zheng Hongping,Shao Fangyuan,Martin Scots,Xu Xiaoling,Deng Chu-Xia
Publisher
Springer Science and Business Media LLC
Reference56 articles.
1. Hall, M. D., Okabe, M., Shen, D. W., Liang, X. J. & Gottesman, M. M. The role of cellular accumulation in determining sensitivity to platinum-based chemotherapy. Annu Rev Pharmacol Toxicol 48, 495–535 (2008).
2. Giaccone, G. Clinical perspectives on platinum resistance. Drugs 59 Suppl 4, 9–17, discussion 37–18 (2000).
3. Cepeda, V. et al. Biochemical mechanisms of cisplatin cytotoxicity. Anticancer Agents Med Chem 7, 3–18 (2007).
4. Agrawal, L. S. & Mayer, I. A. Platinum agents in the treatment of early-stage triple-negative breast cancer: is it time to change practice? Clinical advances in hematology & oncology: H&O 12, 654–658 (2014).
5. Tan, X. et al. Clinical significance of a point mutation in DNA polymerase beta (POLB) gene in gastric cancer. Int J Biol Sci 11, 144–155 (2015).
Cited by
52 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献